Drug General Information
Drug ID
D0FY1W
Former ID
DIB001969
Drug Name
Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy
Synonyms
Thymidine kinase-expressing adenovirus and ganciclovir suicide genetherapy (cancer); Ad5-SSTR/TK-RGD; Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy (cancer), University of Alabama
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [522769]
Company
University of Alabama at Birmingham
Target and Pathway
Target(s) Thymidine kinase Target Info Modulator [1572591]
References
Ref 522769ClinicalTrials.gov (NCT00964756) A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers. U.S. National Institutes of Health.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.